Refined genetic mapping and proteolipid protein mutation analysis in X-linked pure hereditary spastic paraplegia

Neurology

Volumn 46, Issue 4, 1996, Pages 1112-1117

  Cambi, F ^a,d   Tang, X M ^a   Cordray, P ^b   Fain, P R ^b   Keppen, L D ^c   Barker, D F ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; X CHROMOSOME LINKED DISORDER;

ADULT; AMINO ACID SEQUENCE; APOPROTEINS; BASE SEQUENCE; CHILD; CHROMOSOME MAPPING; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; MUTATION; MYELIN PROTEOLIPID PROTEIN; PARAPARESIS, TROPICAL SPASTIC; PEDIGREE; X CHROMOSOME;

EID: 0029863607     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.4.1112     Document Type: Article

References (36)

1. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983;1:1151-1155.
2. Harding AE. The hereditary ataxias and related disorders, Clinical neurology and neurosurgery monographs, vol 6, chaps 12-14. New York: Churchill Livingstone, 1984:174-211.
3. Gutman DH, Fishbeck KH, Kamholz J. Complicated hereditary spastic paraparesis with cerebral white matter lesions. Am J Med Genet 1989;36:251-257.
4. Goldblatt J, Ballo R, Sachs B, Moosa A. X-linked spastic paraplegia: evidence for homogeneity with a variable phenotype. Clin Genet 1989;35:116-120.
5. Johnston AW, McKusick VA. A sex-linked recessive form of spastic paraplegia. Am J Hum Genet 1962;14:83-96.
6. Thurmon TF, Walker BA, Scott CI, Abbott MH. Birth defects. Original article series VII. Baltimore: Williams & Wilkins, 1971:219-221.
7. Zastz M, Penha-Serrano C, Otto PA. X-linked recessive type of pure spastic paraplegia in a large pedigree: absence of detectable linkage with Xg. J Med Genet 1976;13:217-222.
8. Keppen LD, Leppert MF, O'Connell P, et al. Etiological heterogeneity in X-linked spastic paraplegia. Am J Hum Genet 1987;41:933-943.
9. Cambi F, Tartaglino L, Lublin FD, McCarren D. X-linked pure familial spastic paraparesis: characterization of a large kindred with magnetic resonance imaging studies. Arch Neurol 1995;52:665-669.
10. Jouet M, Rosenthal A, Armstrong G, et al. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene. Nature Genet 1994;7:402-407.
11. Vits L, Van Camp G, Coucke P, et al. MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nature Genet 1994;7:408-413.
12. Saugier-Veber P, Munnich A, Bonneau D, et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet 1994; 6:257-262.
13. Kobayashi H, Hoffman EP, Marks HG. The rumpshaker mutation in spastic paraplegia. Nature Genet 1994;7:351-352.
14. Trofatter JA, Pratt VM, Dlouhy SR, Hodes ME. Ahall polymorphism in human X-linked proteolipid protein gene (PLP). Nucleic Acids Res 1990;19:6057.
15. Barker DF, Fain PR. Definition and mapping of STSs at STR and RFLP loci in Xp11-Xq22. Genomics 1993;18:712-716.
16. Doll R, Natowicz MR, Schiffmann R, Smith FI. Molecular diagnostics for myelin proteolipid gene mutations in Pelizaeus-Merzbacher disease. Am J Hum Genet 1992;51:161-169.
17. Gencic S, Abuelo D, Ambler M, Hudson LD. Pelizaeus-Merzbacher disease: An X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein. Am J Hum Genet 1989;45:435-442.
18. Willard HF, Cremers F, Mandell JL, Monaco AP, Nelson DL, Schlessinger D. Report and abstracts of the Fifth International Workshop on Human X chromosome mapping. Cytogenet Cell Genet 1994;67:295-358.
19. Fain PR, Kort EN, Chance PF, Nguyen K, Econs MJ, Barker DF. A 2D crossover-based map of the human X chromosome as a model for map integration. Nature Genet 1995;9:261-265.
20. Nave KA, Lai C, Bloom FE, Milner RJ. Splice site selection in the gene for proteolipid protein (PLP) gene transcript and primary structure of the DM20 protein of CNS myelin. Proc Natl Acad Sci. USA 1987;84:5665-5669.
21. Macklin WB, Campagnoni CW, Deininger PL, Gardinier MV. Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res 1987;18:383-394.
22. Popot J-L, Pham Dinh D, Dautigny A. Major myelin proteolipid: the 4-alfa-helix topology. J Membr Biol 1991;120:233-246.
23. Schneider A, Montague P, Griffiths I, et al. A mutation of the proteolipid protein gene uncoupling hypomyelination from glial cell death. Nature 1992;358:758-761.
24. Bridge PJ, Wilkins PJ. The role of proteolipid protein gene mutations in Pelizaeus-Merzbacher disease [abstract]. Am J Hum Genet 1992;51:A209.
25. Pham-Dinh D, Popot J-I, Boespflug-Tanguy O, et al. Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid. Proc Natl Acad Sci USA 1991;88:7562-7566.
26. Iwaki A, Muramoto T, Iwaki I, et al. A missense mutation in the proteolipid protein gene responsible for Pelizaeus-Merzbacher disease in a Japanese family. Hum Mol Genet 1993;2:19-22.
27. Otterbach B, Stoffel W, Ramaekers V. A novel mutation in the proteolipid protein gene leading to Pelizaeus-Merzbacher disease. Biol Chem Hoppe Seyler 1993;374:75-83.
28. Strautnieks S, Rutland P, Winter RM, Baraitser M, Malcolm S. Pelizaeus-Merzbacher disease: detection of mutations Thr181-Pro and leu223-Pro in the proteolipid protein gene, and prenatal diagnosis. Am J Hum Genet 1992;51:871-878.
29. Yan Y, Lagenauer C, Narayanan V. Molecular cloning of M6: identification of a PLP/DM20 gene family. Neuron 1993;11: 423-431.
30. Fransen E, Scrander-Stumpel C, Vits L, Coucke P, Van Camp G, Willems PG. X-linked Hydrocephalus and MASA syndrome present in one family are due to a single missense mutation in exon 28 of the L1CAM gene. Hum Mol Genet 1994;3:2255-2256.
31. Ikenaka K, Kagawa T, Mikoshiba K. Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and nonglial cells. J Neurochem 1992;58:2248-2253.
32. Campagnoni CW, Garbay B, Micevych P, et al. DM-20 messenger RNA splice product of the myelin proteolipid gene is expressed in the murine heart. J Neurosci Res 1992;33:148-155.
33. Cremers FP, Pfeiffer RA, van de Pol TJ, et al. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-22 region. Hum Genet 1987;77:23-27.
34. Ellis D, Malcolm S. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nature Genet 1994;6:333-334.
35. Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci 1993;14:383-394.
36. Boespflug-Tanguy O, Mimault C, Melki J, et al. Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. PMD Clinical Group. Am J Hum Genet 1994;55:461-467.